Jupiter Life Line Hospitals Ltd

AI
Jupiter Life Lin Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents
AI

Jupiter Life Line Hospitals Ltd

₹ 285 1.70%
05 Nov 12:36 p.m.
jupiterhospital.com BSE: 543980 NSE: JLHL
About

Incorporated in 2007, Jupiter Life Line Hospitals Limited is a multi-specialty tertiary and quaternary healthcare provider in the Mumbai Metropolitan Area (MMR) and western region of India.[1]

Key Points

Hospital Portfolio:[1][2]
The company operates 4 hospitals across Thane, Pune, Indore & Dombivli with 1,248 operational beds (Census Beds and Non-Census Beds: 140).

Website BSE NSE
  • Market Cap ₹ 9,333 Cr.
  • Current Price ₹ 285
  • High / Low ₹ 340 / 230
  • Stock P/E 49.1
  • Book Value ₹ 49.7
  • Dividend Yield 0.07 %
  • ROCE 14.8 %
  • ROE 13.1 %
  • Face Value ₹ 2.00
Edit ratios

Pros

  • Company has delivered good profit growth of 143% CAGR over last 5 years

Cons

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Services Hospital

Part of BSE Healthcare BSE 1000 BSE Hospitals Nifty Smallcap 500

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
263 273 291 289 335 333 337 353 394 365 388 411 456
202 211 228 223 257 256 257 275 301 282 299 332 350
Operating Profit 61 62 63 65 78 76 80 78 92 83 89 79 107
OPM % 23% 23% 22% 23% 23% 23% 24% 22% 23% 23% 23% 19% 23%
3 8 10 7 7 7 7 13 11 3 11 11 11
Interest 12 1 1 1 1 3 6 8 8 8 9 13 14
Depreciation 11 11 10 11 14 14 18 21 21 22 23 26 28
Profit before tax 41 58 62 60 70 67 63 62 74 57 68 51 75
Tax % 19% 25% 27% 26% 26% 22% 28% 29% 23% 25% 26% 26% 25%
34 44 45 45 52 52 45 44 57 42 50 38 56
EPS in Rs 1.03 1.33 1.37 1.36 1.58 1.59 1.38 1.34 1.75 1.30 1.53 1.14 1.71
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
463 486 733 893 1,073 1,302 1,500 1,621
379 419 580 691 831 999 1,156 1,262
Operating Profit 84 67 153 201 242 303 343 359
OPM % 18% 14% 21% 23% 23% 23% 23% 22%
0 4 4 8 22 25 37 35
Interest 26 39 44 42 26 11 33 43
Depreciation 26 31 36 39 42 57 88 100
Profit before tax 33 2 77 129 195 261 260 250
Tax % 10% 248% 34% 43% 10% 26% 25%
30 -2 51 73 177 194 194 187
EPS in Rs 1.17 -0.09 2.01 2.58 5.39 5.89 5.92 5.68
Dividend Payout % 0% 0% 0% 0% 4% 3% 3%
Compounded Sales Growth
10 Years: %
5 Years: 25%
3 Years: 19%
TTM: 14%
Compounded Profit Growth
10 Years: %
5 Years: 143%
3 Years: 37%
TTM: -4%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: 12%
1 Year: -10%
Return on Equity
10 Years: %
5 Years: 17%
3 Years: 16%
Last Year: 13%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Sep 2026
Equity Capital 51 51 51 57 66 66 66 66
Reserves 186 188 243 309 1,103 1,291 1,479 1,565
272 426 495 469 0 393 584 669
94 124 120 151 112 168 235 261
Total Liabilities 603 789 909 986 1,281 1,917 2,363 2,560
435 630 684 720 718 978 1,384 1,439
CWIP 10 26 27 29 74 185 129 194
Investments 2 7 3 2 17 507 486 385
156 126 195 235 473 247 364 543
Total Assets 603 789 909 986 1,281 1,917 2,363 2,560

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
74 123 137 176 115 267 268
-43 -295 -84 -94 -246 -497 -442
-32 184 32 -51 128 297 136
Net Cash Flow -1 12 85 31 -3 66 -38
Free Cash Flow 46 -118 46 100 29 -60 -234
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit 106% 198% 95% 97% 68% 109% 97%

Ratios

Consolidated / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 35 16 14 19 19 12 18
Inventory Days 64 48 39 44 41 38 49
Days Payable 268 217 157 164 120 99 121
Cash Conversion Cycle -169 -152 -104 -101 -59 -49 -54
Working Capital Days 17 -7 -24 -24 -5 -19 -21
ROCE % 7% 17% 21% 22% 18% 15%

Insights

In beta
Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
ALOS
days

Log in to view insights

Please log in to see hidden values.

Login
ARPOB
Rs
Average Occupancy Rate
%
Census Beds
beds
Insurance Payor Mix
%
IPD Volume
thousand discharges
OPD Volume
thousand visits
Non-Census Beds
beds

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
40.91% 40.91% 40.91% 40.91% 40.91% 40.91% 40.91% 40.91% 40.91% 40.91% 40.91% 40.91%
3.96% 4.17% 6.06% 8.84% 10.04% 10.04% 9.77% 9.06% 8.48% 8.48% 9.37% 9.13%
13.92% 14.16% 13.85% 13.46% 15.75% 15.64% 15.82% 16.97% 17.44% 17.01% 16.51% 19.13%
41.19% 40.76% 39.18% 36.79% 33.31% 33.43% 33.51% 33.08% 33.17% 33.60% 33.20% 30.85%
No. of Shareholders 39,34835,10735,79734,08133,91433,95634,19234,36133,62032,98533,19433,255

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls